OMNEVA Trademark

Trademark Overview

On Thursday, October 27, 2011, a trademark application was filed for OMNEVA with the United States Patent and Trademark Office. The USPTO has given the OMNEVA trademark a serial number of 85457778. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 24, 2015. This trademark is owned by Glaxo Group Limited. The OMNEVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
omneva

General Information

Serial Number85457778
Word MarkOMNEVA
Filing DateThursday, October 27, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 24, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 1, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, August 24, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 24, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, December 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 12, 2014EXTENSION 5 GRANTED
Wednesday, December 10, 2014EXTENSION 5 FILED
Wednesday, December 10, 2014TEAS EXTENSION RECEIVED
Wednesday, June 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 24, 2014EXTENSION 4 GRANTED
Monday, June 23, 2014EXTENSION 4 FILED
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Thursday, January 16, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 15, 2014EXTENSION 3 GRANTED
Friday, January 10, 2014EXTENSION 3 FILED
Friday, January 10, 2014TEAS EXTENSION RECEIVED
Wednesday, August 7, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 6, 2013EXTENSION 2 GRANTED
Friday, July 5, 2013EXTENSION 2 FILED
Friday, August 2, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 5, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 4, 2013EXTENSION 1 GRANTED
Friday, January 4, 2013EXTENSION 1 FILED
Friday, January 4, 2013TEAS EXTENSION RECEIVED
Tuesday, July 24, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 29, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 29, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 23, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 23, 2012ASSIGNED TO LIE
Friday, March 30, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 30, 2012EXAMINER'S AMENDMENT ENTERED
Friday, March 30, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 30, 2012EXAMINERS AMENDMENT E-MAILED
Friday, March 30, 2012EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 21, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2012NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2012NON-FINAL ACTION WRITTEN
Saturday, February 11, 2012ASSIGNED TO EXAMINER
Tuesday, November 1, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 31, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

omneva pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological